RPT904 at both Q8W and Q12W dosing showed comparable efficacy and safety to omalizumab at Q4W dosing - Efficacy sustained at Week 16 after a single dose of RPT904 - Well tolerated with no serious ...

Sigma Lithium announces that it was included as a case study in a key industry report. The report "Climate and Nature Solutions in Brazil" was published by Instituto Itausa, an organization dedicated ...

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed ...

From Crescent City to El Centro, Californians rally Oct. 18 against Trump-era policies in statewide ‘No Kings Day’ demonstrations.

For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s first needle-free ...

The FDA has cleared the Elecsys pTau181 test as an aid in early detection of amyloid pathology in the primary care setting for adults aged 55 years and older presenting with signs, symptoms or ...